Effective coronavirus reduction by various production steps during the manufacture of plasma‐derived medicinal products

Saved in:
Bibliographic Details
Published inTransfusion (Philadelphia, Pa.) Vol. 60; no. 6; pp. 1334 - 1335
Main Authors Schräder, Tobias, Koch, Julia, Ross, Rachael, Schäfer, Wolfram, Keiner, Björn, Roth, Nathan J., Widmer, Eleonora
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.06.2020
Wiley Subscription Services, Inc
Subjects
Animals
Betacoronavirus - physiology
Biological Products - chemical synthesis
Biological Products - isolation & purification
Coronaviruses
Drug Contamination - prevention & control
Humans
Hydrogen-Ion Concentration
Immunoglobulins, Intravenous - biosynthesis
Immunoglobulins, Intravenous - isolation & purification
Letter to the Editor
Manufactured Materials - virology
Pasteurization - methods
Pharmaceutical Preparations - chemical synthesis
Pharmaceutical Preparations - isolation & purification
Plasma - chemistry
Plasma - virology
Safety Management - methods
Safety Management - standards
SARS-CoV-2
Swine - virology
Transmissible gastroenteritis virus - physiology
Treatment Outcome
Virus Inactivation
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0041-1132
1537-2995
DOI:10.1111/trf.15850